Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.90 Analyst target: $4.03 Upside: -63.03%
Burning Rock Biotech Limited primarily develops and provides screening tests for cancer therapies in the People's Republic of China. The company is headquartered in Guangzhou, China.
See the full interactive analysis & chart →Informational only — not investment advice.